Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Changes in Shareholders' Equity

v3.25.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Share Capital
Contributed Surplus
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning Balance at Dec. 31, 2022 $ 258,646 $ 19,843 $ 4,265 $ (220,255) $ 62,499
Beginning Balance (in shares) at Dec. 31, 2022 224,699,621        
Shares issued for cash $ 44,033 0 0 0 44,033
Shares issued for cash (in shares) 43,525,809        
Less share issue costs $ (3,165) 0 0 0 (3,165)
Exercise of warrants $ 337 0 0 0 337
Exercise of warrants (in shares) 206,515        
Exercise of stock options $ 2,023 (611) 0 0 $ 1,412
Exercise of stock options (in shares) 2,225,098       2,225,098
Redemption of RSUs $ 308 (377) 0 0 $ (69)
Redemption of RSUs (in shares) 241,857        
Stock compensation $ 0 1,026 0 0 1,026
Comprehensive income (loss) 0 0 (547) (30,656) (31,203)
Ending Balance at Dec. 31, 2023 $ 302,182 19,881 3,718 (250,911) 74,870
Ending Balance (in shares) at Dec. 31, 2023 270,898,900        
Shares issued for cash $ 97,568 0 0 0 97,568
Shares issued for cash (in shares) 82,662,325        
Less share issue costs $ (4,683) 0 0 0 (4,683)
Exercise of warrants $ 15,849 0 0 0 15,849
Exercise of warrants (in shares) 8,188,250        
Exercise of stock options $ 2,326 (319) 0 0 $ 2,007
Exercise of stock options (in shares) 2,351,563       2,351,563
Redemption of RSUs $ 0 (60) 0 0 $ (60)
Reclassify stock options to liabilities 0 (1,310) 0 0 (1,310)
Stock compensation 0 1,276 0 0 1,276
Comprehensive income (loss) 0 0 471 (53,189) (52,718)
Ending Balance at Dec. 31, 2024 $ 413,242 $ 19,468 $ 4,189 $ (304,100) $ 132,799
Ending Balance (in shares) at Dec. 31, 2024 364,101,038